Washington state has some of the world’s top companies developing targeted antibody drugs. Speakers from Seattle Genetics, Alder Biopharmaceuticals, VLST, Arch Venture Partners, Theraclone Sciences, Omeros and more will be on hand for an “antibody hub” summit organized by the WBBA on April 10. For more information on how to register, click here.